Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Schorb E, Isbell LK, Kerkhoff A, Mathas S, Braulke F, Egerer G, Röth A, Schliffke S, Borchmann P, Brunnberg U, Kroschinsky F, Möhle R, Rank A, Wellnitz D, Kasenda B, Pospiech L, Wendler J, Scherer F, Deckert M, Henkes E, von Gottberg P, Gmehlin D, Backenstraß M, Jensch A, Burger-Martin E, Grishina O, Fricker H, Malenica N, Orbán A, Duyster J, Ihorst G, Finke J, Illerhaus G. Schorb E, et al. Among authors: scherer f. Lancet Haematol. 2024 Mar;11(3):e196-e205. doi: 10.1016/S2352-3026(23)00371-X. Epub 2024 Jan 29. Lancet Haematol. 2024. PMID: 38301670 Clinical Trial.
Stringent Base Specific and Optimization-Free Multiplex Mediator Probe ddPCR for the Quantification of Point Mutations in Circulating Tumor DNA.
Schlenker F, Kipf E, Deuter M, Höffkes I, Lehnert M, Zengerle R, von Stetten F, Scherer F, Wehrle J, von Bubnoff N, Juelg P, Hutzenlaub T, Borst N. Schlenker F, et al. Among authors: scherer f. Cancers (Basel). 2021 Nov 16;13(22):5742. doi: 10.3390/cancers13225742. Cancers (Basel). 2021. PMID: 34830896 Free PMC article.
Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M. Chabon JJ, et al. Among authors: scherer f. Nat Commun. 2016 Nov 14;7:13513. doi: 10.1038/ncomms13513. Nat Commun. 2016. PMID: 27841271 Free PMC article. No abstract available.
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.
Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kückelhaus J, Vollmer L, Goeldner JM, Behringer SP, Scherer F, Boerries M, Follo M, Weiss T, Delev D, Kernbach J, Franco P, Schallner N, Dierks C, Carro MS, Hofmann UG, Fung C, Sankowski R, Prinz M, Beck J, Salié H, Bengsch B, Schnell O, Heiland DH. Ravi VM, et al. Among authors: scherer f. Nat Commun. 2022 Feb 17;13(1):925. doi: 10.1038/s41467-022-28523-1. Nat Commun. 2022. PMID: 35177622 Free PMC article.
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M. Chaudhuri AA, et al. Among authors: scherer f. Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24. Cancer Discov. 2017. PMID: 28899864 Free PMC article.
Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.
Lauer EM, Waterhouse M, Braig M, Mutter J, Bleul S, Duque-Afonso J, Duyster J, Marks R, Reinacher PC, Prinz M, Illerhaus G, Finke J, Schorb E, Scherer F. Lauer EM, et al. Among authors: scherer f. Br J Haematol. 2020 Jul;190(2):e110-e114. doi: 10.1111/bjh.16759. Epub 2020 May 26. Br J Haematol. 2020. PMID: 32452526 Free article. No abstract available.
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.
Waldeck S, Mitschke J, Wiesemann S, Rassner M, Andrieux G, Deuter M, Mutter J, Lüchtenborg AM, Kottmann D, Titze L, Zeisel C, Jolic M, Philipp U, Lassmann S, Bronsert P, Greil C, Rawluk J, Becker H, Isbell L, Müller A, Doostkam S, Passlick B, Börries M, Duyster J, Wehrle J, Scherer F, von Bubnoff N. Waldeck S, et al. Among authors: scherer f. Mol Oncol. 2022 Jan;16(2):527-537. doi: 10.1002/1878-0261.13116. Epub 2021 Oct 31. Mol Oncol. 2022. PMID: 34653314 Free PMC article.
A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin.
Strüßmann T, Wäsch R, Scherer F, Mutter JA, Pfeifer D, Bartsch I, Giesler S, Graziani G, Duyster J, Finke J, Marks R. Strüßmann T, et al. Among authors: scherer f. Leuk Lymphoma. 2022 Sep;63(9):2260-2262. doi: 10.1080/10428194.2022.2074991. Epub 2022 May 20. Leuk Lymphoma. 2022. PMID: 35593017 No abstract available.
115 results